Welcome to the third issue of the NEMO newsletter. A lot has changed since the last issue of the newsletter and we wish to thank you all for the work involved in these changes. Since the last PGB meeting in Amsterdam in September 2012 a decision was made for an early termination of the NEMO-1 study, this was not an easy decision to come to but we all agreed that it was the right decision to make. We look forward to NEMO-2 and hope that the experience gained during NEMO-1 will make this a much easier process.

On a sadder note we say good bye to Havinder Hara our clinical trial coordinator, who is moving to a new position. We wish to thank Havinder for all the hard work she put into NEMO-1 and wish her the best of luck for the future.